Macrophage cell therapy: a new hope for chronic liver disease patients
Drug Target Review
AUGUST 28, 2024
Available from: [link] About the author Cliff Brass, MD PhD FAASLD, Chief Medical Officer at Resolution Therapeutics Cliff Brass is an expert in clinical development with special expertise in liver disease and over 25 years of experience in pharma. He is named on 15 patents relating to drug development in liver disease.
Let's personalize your content